Post-progression survival is highly linked to overall survival in patients with non-small-cell lung cancer harboring sensitive EGFR mutations treated with first-line epidermal growth factor receptor-tyrosine kinase inhibitors
| Image |  |
|---|---|
| Description | scientific article published on 08 October 2019 |
| Author/s |
author: Kyoichi Kaira Hisao Imai |
| Publication date | October 8, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |